Oncobiome Congress | Kisaco Research
Uncovering the impact of the microbiome in the aetiology & treatment of cancer
Boston, USA
8-9 May, 2018
Download Agenda
The Audience
Register

Why Attend

By attending the Cancer Microbiome Congress you will: 

  • Discover how the microbiome interacts with immunotherapies such as PD1 to improve the efficacy of immuno-oncology drugs.
  • Build the foundations of interdisciplinary collaboration between the fields of microbiology, immunology & oncology to accelerate this pioneering field.
  • Learn how to use the microbiome to determine how to better stratify patients, improve patient outcomes and further the potential of immunotherapy.
  • Meet and hear from companies such as Seres and Vedanta who are leading the way in developing microbial therapeutics, to build business partnerships & research collaborations.
  • Discover the breakthrough research into the mechanisms behind the microbiome’s influence on cancer initiation and progression.
75+
Attendees
15+
Speakers
8+
Hours of networking

Who Will Be There

40%
Leading academics
40%
Biotechs and big Pharma
20%
Vendors and Industry Supporting Companies

Leading academics

Biotechs and big Pharma

Vendors and Industry Supporting Companies

The Speakers

 

Bruce Roberts

Chief Scientific Officer
Vedanta Biosciences

Bruce Roberts

Chief Scientific Officer
Vedanta Biosciences
 

Vancheswaran Gopalakrishnan

Wargo Lab
MD Anderson

Vancheswaran Gopalakrishnan

Wargo Lab
MD Anderson
 

James Goedert

MD, Division of Cancer Epidemiology and Genetics
National Cancer Institute, NIH

James Goedert

MD, Division of Cancer Epidemiology and Genetics
National Cancer Institute, NIH
 

Wendy Garrett

Professor of Immunology and Infectious Diseases
Harvard School of Medicine

Wendy Garrett

Professor of Immunology and Infectious Diseases
Harvard School of Medicine
 

Pierre Belichard

CEO
Enterome

Pierre Belichard

CEO
Enterome
 

Dr David Cook

Chief Scientific Officer
Seres

David Cook is the Executive Vice President of R&D and Chief Scientific Officer of Seres Therapeutics, Inc. (“Seres”). He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. Prior to joining Seres, he served as the Chief Operating Officer for the International AIDS Vaccine Initiative (IAVI), a global R&D organization. Prior to IAVI, Dr.

Dr David Cook

Chief Scientific Officer
Seres

David Cook is the Executive Vice President of R&D and Chief Scientific Officer of Seres Therapeutics, Inc. (“Seres”). He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. Prior to joining Seres, he served as the Chief Operating Officer for the International AIDS Vaccine Initiative (IAVI), a global R&D organization. Prior to IAVI, Dr.

 

Marcel Van Den Brink

Physician-scientist
Memorial Sloane Kettering

Marcel Van Den Brink

Physician-scientist
Memorial Sloane Kettering
 

Stefan Scherer

Vice President, Head Early Development, Strategy and Innovation
Novartis

Stefan Scherer

Vice President, Head Early Development, Strategy and Innovation
Novartis

The Agenda

Download Full Agenda

Event Sponsors

Media Partners

Become a Sponsor or Exhibitor

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event
with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.


With our extensive marketing experience and strategy, your partnership with the conference will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts.


CONTACT US: Ask us about the different ways you can get involved.

Contact our sponsorship team to find out more about each package by emailing [email protected] or by calling: +44 (0)20 3696 2925.

Venue

Please check back in as we are confirming the location for the Oncobiome Congress. Details will be updated on the site. 

Image result for Boston, USA

Conference Packages

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: discounts cannot be combined.

Wednesday, January 17, 2018 to Friday, March 23, 2018
Academics
$799
Early Bird (Register and pay by March 23). Save $100.
Main 2 Day Conference - All Sessions
Access to all Networking & Social Functions
Refreshments, Breakfast & Luncheon
Monday, January 22, 2018 to Friday, March 23, 2018
Pharmaceutical & Biotech
$1599
Early Bird (Register and pay by March 23). Save $200.
Main 2 Day Conference - All Sessions
Access to all Networking & Social Functions
Refreshments, Breakfast & Luncheon
Monday, January 22, 2018 to Friday, March 23, 2018
Service Providers & Vendors
$1999
Early Bird (Register and pay by March 23). Save $300.
Main 2 Day Conference - All Sessions
Access to all Networking & Social Functions
Refreshments, Breakfast & Luncheon
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us